JobCubby JobCubby
Sign up
Larimar Therapeutics

Larimar Therapeutics

Clinical-stage biotechnology company focused on developing treatments for complex rare diseases.

LinkedIn
Location
—
Roles tracked
0
In pipeline
0
Tracking since
—

At a glance

You're tracking 0 roles at Larimar Therapeutics. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology
Company size
87 people
Headquarters
Bala Cynwyd, PA +1 more
Founded
2016
Type
Public Company
Total funding
$721.7M

Larimar Therapeutics, Inc. (Nasdaq:LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.

Biotechnology and Rare Disease
1 open role at Larimar Therapeutics on the job board

Open roles at Larimar Therapeutics